Brady Todd C's Purchase of Aldeyra Therapeutics, Inc. Common Stock
2026-06-05SEC Filing 4 (0001193125-26-259637)
On June 3, 2026, Brady Todd C., President and CEO of Aldeyra Therapeutics, Inc. (ALDX), acquired 250,000 shares of common stock under a Form 4 filing. The purchase was made at a weighted average price of $1.6738 per share, with individual transaction prices ranging from $1.64 to $1.70. Following this transaction, Mr. Brady now owns 1,721,298 shares of common stock. The filing indicates this was a direct acquisition.